Citation: M. Cohen et al., EFFECT OF LOW-MOLECULAR-WEIGHT HEPARIN ON PRESPECIFIED PATIENT SUBGROUPS WITH REST UNSTABLE ANGINA OR NON-Q-WAVE MYOCARDIAL-INFARCTION, Circulation, 98(17), 1998, pp. 2945-2945
Authors:
COHEN M
TURPIE AGG
DEMERS C
GURFINKEL E
FROMELL G
LANGER A
GOODMAN S
CALIFF R
FOX K
PREMMEREUR J
BIGONZI F
Citation: M. Cohen et al., BLIND COMPARISON OF ENOXAPARIN (A LOW-MOLECULAR-WEIGHT HEPARIN) WITH STANDARD HEPARIN IN THE TREATMENT OF UNSTABLE CORONARY-ARTERY DISEASE THE ESSENCE TRIAL, Thrombosis and haemostasis, 1997, pp. 1528-1528
Authors:
COHEN M
WEATHERLEY B
LEE KL
GURFINKEL EP
FROMELL G
GOODMAN SG
FOX KA
Citation: M. Cohen et al., MULTIVARIABLE ANALYSIS OF PREDICTORS OF RECURRENT ISCHEMIC EVENTS ANDDEATH IN UNSTABLE ANGINA AND NON-Q-WAVE INFARCTION AFTER TREATMENT WITH COMBINATION ANTITHROMBOTIC THERAPY - RESULTS FROM THE ESSENCE TRIAL, Circulation, 96(8), 1997, pp. 3328-3328
Authors:
COHEN M
DEMERS C
GURFINKEL E
FROMELL G
LANGER A
TURPIE AGG
Citation: M. Cohen et al., PRIMARY END-POINT ANALYSIS FROM THE ESSENCE TRIAL - ENOXAPARIN VS UNFRACTIONATED HEPARIN IN UNSTABLE ANGINA AND NON-Q-WAVE INFARCTION, Circulation, 94(8), 1996, pp. 3240-3240
Authors:
CUTLER NR
EFF J
FROMELL G
BRASS EP
ARCHER S
CHRYSANT SG
FIDDES R
Citation: Nr. Cutler et al., DOSE-RANGING STUDY OF A NEW, ONCE-DAILY DILTIAZEM FORMULATION FOR PATIENTS WITH STABLE ANGINA, Journal of clinical pharmacology, 35(2), 1995, pp. 189-195